GILEAD SCIENCES 401K PLAN
Investment Model Portfolios

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. The company was founded in 1987 and is headquartered in Foster City, California.

Total Available Funds: 25
Asset Class Ticker Description
US EQUITY
LARGE GROWTH TRBCX T. Rowe Price Blue Chip Growth
MID-CAP VALUE ABSKX ABF Small Cap Value
LARGE BLEND VINIX Vanguard Institutional Index
MID-CAP BLEND FSEMX Spartan Extended Market Index
LARGE VALUE FEQIX Fidelity Equity Income
LARGE GROWTH FDGRX Fidelity Growth Company
MID-CAP BLEND FLPSX Fidelity Low Priced Stock
REAL ESTATE
REAL ESTATE TRREX T. Rowe Price Real Estate
INTERNATIONAL EQUITY
Foreign Small/Mid Value FTFAX Templeton Institutional Foregin Smaller Companies
Foreign Large Growth FDIVX Fidelity Diversified International
FIXED INCOME
Intermediate-Term Bond VBMFX Vanguard Total Bond market Index Sig
Intermediate-Term Bond FTHRX Fidelity Intermediate Bond
Others
Retirement Income FFFAX Fidelity Freedom Income
Target Date 2000-2010 FFFBX Fidelity Freedom 2000
Target Date 2000-2010 FFFCX Fidelity Freedom 2010
Target Date 2016-2020 FFFDX Fidelity Freedom 2020
Target Date 2026-2030 FFFEX Fidelity Freedom 2030
Target Date 2036-2040 FFFFX Fidelity Freedom 2040
Target Date 2000-2010 FFFVX Fidelity Freedom 2005
Target Date 2011-2015 FFVFX Fidelity Freedom 2015
Target Date 2021-2025 FFTWX Fidelity Freedom 2025
Target Date 2031-2035 FFTHX Fidelity Freedom 2035
Target Date 2041-2045 FFFGX Fidelity Freedom 2045
Target Date 2050+ FFFHX Fidelity Freedom 2050
ROOT CASH Fidelity Managed Income Portfolio

The following is a moderate-risk model portfolio constructed from the investment options of GILEAD SCIENCES 401K PLAN.

This portfolio is proactively monitored and rebalanced on a monthly basis when needed, ensuring it remains in line with its target allocation. We offer customization features, allowing subscribers to tailor the portfolio to align with their own risk tolerance and return expectations by changing risk profile parameter.

Our model portfolio is rooted in the MyPlanIQ Asset Allocation Composite (AAC) strategy. This dynamic (tactical) asset allocation and quantitative fund selection algorithm prioritize risk management by dynamically adjusting stock allocations based on prevailing asset momentum. Extensive research has shown that this momentum-based tactical approach can potentially reduce temporary losses while maintaining or outperforming traditional buy-and-hold strategies.

Both historical back test and real-time portfolio return and risk data are shown in the table on this page. These metrics are compared with stock and moderate allocation index funds.

Furthermore, subscribers have the option to explore alternative strategies such as Strategic Asset Allocation Optimal (SAA) and Tactical Asset Allocation (TAA) to further customize their model portfolio. See our investment methodology for more details on the investment strategies